http://www.fda.gov/fdac/features/2006/606_hiv.html
U.S. Food and Drug Administration
This consumer publication discusses the approval by the Food and Drug Administration of Atripla Tablets, a fixed-dose combination of three widely used antiretroviral drugs in a single tablet for the treatment of HIV-1 infection in adults. Atripla is to be taken once a day alone or in combination with other antiretroviral products. ith HIV-1.